Most Recent Articles by Kathy Boltz, PhD
Researchers have developed a compound that delays leukemia in mice and kills leukemia cells in human tissue samples, which gives hope it could be used to improve regular leukemia therapy.
When patients with cancer in different Asian American subgroups were examined, their cancer-specific mortality was found to be far lower than that of non-Hispanic white patients.
Implementation of video-based decision aids for men lowered rates of elective surgery for benign prostatic hyperplasia (BPH) and decreased rates of active treatment for localized prostate cancer.
Two studies do not show protective effect of delayed radiation compared to earlier radiation for prostate cancer.
Experiments in mice suggest that elevated blood levels of the fatty acid derived from fish oil may induce resistance to chemotherapy.
More Articles by Kathy Boltz, PhD
Cervical cancer screenings important for young female patients with inflammatory bowel disease (IBD)Apr 14,2015
- Vitamin D and prostate cancer: Higher intake improves active surveillance outcomes
- Triple combination of two targeted therapies + immunotherapy is more effective in advanced melanoma
- Physical activity associated with less chemo-induced peripheral neuropathy
- mHealth app assesses breast cancer risk and aids prevention
- Study identifies those at high risk for developing pancreatic cancer
- Promising drug offers new paradigm for treating leukemia
- Statin use inversely linked to risk of pancreatic cancer
- Coffee may reduce risk of breast cancer recurrence
- Phase II trial shows drug combination promising in advanced melanoma
- Biennial mammography optimal screening interval for average risk women
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|